Guo‐Long Bu

421 total citations
14 papers, 185 citations indexed

About

Guo‐Long Bu is a scholar working on Oncology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Guo‐Long Bu has authored 14 papers receiving a total of 185 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Epidemiology and 4 papers in Infectious Diseases. Recurrent topics in Guo‐Long Bu's work include Viral-associated cancers and disorders (8 papers), Cytomegalovirus and herpesvirus research (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). Guo‐Long Bu is often cited by papers focused on Viral-associated cancers and disorders (8 papers), Cytomegalovirus and herpesvirus research (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). Guo‐Long Bu collaborates with scholars based in China, Switzerland and United States. Guo‐Long Bu's co-authors include Cong Sun, Mu‐Sheng Zeng, Chu Xie, Yinfeng Kang, Gexin Zhao, Qian Zhong, Xiang‐Wei Kong, Boyu Yuan, Guo‐Kai Feng and Zheng Liu and has published in prestigious journals such as Advanced Materials, Nature Communications and Journal of Virology.

In The Last Decade

Guo‐Long Bu

13 papers receiving 182 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guo‐Long Bu China	7	81	73	55	43	38	14	185
Catherine S. Forconi United States	9	93 1.1×	58 0.8×	109 2.0×	112 2.6×	36 0.9×	20	269
Joselin M. Vargas United States	5	32 0.4×	149 2.0×	51 0.9×	63 1.5×	43 1.1×	8	247
Hiroyasu Kaya Japan	9	38 0.5×	51 0.7×	31 0.6×	61 1.4×	12 0.3×	21	170
Jun Ni China	10	88 1.1×	92 1.3×	41 0.7×	35 0.8×	76 2.0×	23	260
Jennifer Holter Chakrabarty United States	5	95 1.2×	43 0.6×	56 1.0×	26 0.6×	5 0.1×	13	193
Yoshitaka Asakura Japan	6	33 0.4×	20 0.3×	31 0.6×	23 0.5×	23 0.6×	11	126
Catherine Morrissey Australia	6	77 1.0×	24 0.3×	67 1.2×	14 0.3×	84 2.2×	11	229
Mitesh Patel United States	5	109 1.3×	75 1.0×	136 2.5×	65 1.5×	18 0.5×	6	220
Siti Mardhiana Mohamad Malaysia	5	52 0.6×	37 0.5×	36 0.7×	118 2.7×	34 0.9×	7	194
Salahudeen Mohamed Haja Mohideen Singapore	4	29 0.4×	187 2.6×	27 0.5×	47 1.1×	41 1.1×	7	251

Countries citing papers authored by Guo‐Long Bu

Since Specialization

Citations

This map shows the geographic impact of Guo‐Long Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guo‐Long Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guo‐Long Bu more than expected).

Fields of papers citing papers by Guo‐Long Bu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guo‐Long Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guo‐Long Bu. The network helps show where Guo‐Long Bu may publish in the future.

Co-authorship network of co-authors of Guo‐Long Bu

This figure shows the co-authorship network connecting the top 25 collaborators of Guo‐Long Bu. A scholar is included among the top collaborators of Guo‐Long Bu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guo‐Long Bu. Guo‐Long Bu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Sun, Cong, Guo‐Long Bu, Chu Xie, et al.. (2025). Structural basis of Epstein-Barr virus gp350 receptor recognition and neutralization. Cell Reports. 44(1). 115168–115168. 6 indexed citations

Sun, Cong, Chu Xie, Dong‐Chun Hong, et al.. (2025). Chimeric Glycoprotein Nanoparticles Elicit Robust Neutralizing Antibodies Against Epstein–Barr Virus. Advanced Materials. 38(7). e07012–e07012. 1 indexed citations

Bu, Guo‐Long, et al.. (2025). Optimizing mRNA translation efficiency through rational 5′UTR and 3′UTR combinatorial design. Gene. 942. 149254–149254. 3 indexed citations

Li, Ziqian, Wanping Guo, Ning Meng, et al.. (2025). Extracellular vesicles derived EBV tegument protein BRRF2 suppresses cGAS phase separation to promote anti-viral innate immune evasion. Nature Communications. 16(1). 9015–9015.

Li, Z., Meng-Meng Liu, Fei Cao, et al.. (2025). An optimized integrin α6-targeted peptide capable of delivering toxins for melanoma treatment. Journal of Translational Medicine. 23(1). 495–495. 2 indexed citations

Zhang, Lele, Tian Xia, Peng Li, et al.. (2025). Applications of Artificial Intelligence in Biotech Drug Discovery and Product Development. MedComm. 6(8). e70317–e70317. 4 indexed citations

Zhao, Gexin, Guo‐Long Bu, Cong Sun, et al.. (2024). Potent human monoclonal antibodies targeting Epstein-Barr virus gp42 reveal vulnerable sites for virus infection. Cell Reports Medicine. 5(5). 101573–101573. 4 indexed citations

Xie, Chu, Lele Zhang, Yuan-Tao Liu, et al.. (2024). Research landmarks on the 60th anniversary of Epstein-Barr virus. Science China Life Sciences. 68(2). 354–380. 8 indexed citations

Bu, Guo‐Long, Xiang‐Wei Kong, Cong Sun, et al.. (2023). mRNA‐based Vaccines Targeting the T‐cell Epitope‐rich Domain of Epstein Barr Virus Latent Proteins Elicit Robust Anti‐Tumor Immunity in Mice. Advanced Science. 10(35). e2302116–e2302116. 21 indexed citations

10.

Xie, Chu, Guo‐Long Bu, Gexin Zhao, et al.. (2023). Anti‐EBV antibodies: Roles in diagnosis, pathogenesis, and antiviral therapy. Journal of Medical Virology. 95(5). e28793–e28793. 10 indexed citations

11.

Sun, Cong, Chu Xie, Guo‐Long Bu, et al.. (2023). The structure of HSV-1 gB bound to a potent neutralizing antibody reveals a conservative antigenic domain across herpesviruses. 2(3). 141–146. 9 indexed citations

12.

Sun, Cong, et al.. (2022). Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants. Signal Transduction and Targeted Therapy. 7(1). 202–202. 79 indexed citations

13.

Bu, Guo‐Long, Chu Xie, Yinfeng Kang, Mu‐Sheng Zeng, & Cong Sun. (2022). How EBV Infects: The Tropism and Underlying Molecular Mechanism for Viral Infection. Viruses. 14(11). 2372–2372. 33 indexed citations

14.

Kong, Xiang‐Wei, Xiao Zhang, Guo‐Long Bu, et al.. (2022). Vesicular Stomatitis Virus-Based Epstein-Barr Virus Vaccines Elicit Strong Protective Immune Responses. Journal of Virology. 96(9). e0033622–e0033622. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact